These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2337672)

  • 1. Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase.
    Morris SW; Daniel L; Ahmed CM; Elias A; Lebowitz P
    Blood; 1990 May; 75(10):2035-41. PubMed ID: 2337672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
    Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
    Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia.
    Eisenberg A; Silver R; Soper L; Arlin Z; Coleman M; Bernhardt B; Benn P
    Leukemia; 1988 Oct; 2(10):642-7. PubMed ID: 3172841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the site of M-bcr breakpoint with chronic phase duration, blastic crisis lineage and thrombocytosis in Ph1-positive chronic myelogenous leukemia.
    Viniou NA; Matzourani M; Yataganas X; Meletis J; Pangalis G; Loukopoulos D
    Leuk Lymphoma; 1995 Jul; 18(3-4):335-9. PubMed ID: 8535202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.
    Grossman A; Silver RT; Arlin Z; Coleman M; Camposano E; Gascon P; Benn PA
    Am J Hum Genet; 1989 Nov; 45(5):729-38. PubMed ID: 2683759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CML patients in blast crisis have breakpoints localized to a specific region of the BCR.
    Schaefer-Rego K; Dudek H; Popenoe D; Arlin Z; Mears JG; Bank A; Leibowitz D
    Blood; 1987 Aug; 70(2):448-55. PubMed ID: 3038213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular biology of chronic myeloid leukaemia.
    Melo JV
    Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence that the site of the breakpoint in the major breakpoint cluster region (M-bcr) may be a prognostic indicator.
    Mills KI; Hynds SA; Burnett AK; MacKenzie ED; Birnie GD
    Leukemia; 1989 Dec; 3(12):837-40. PubMed ID: 2685475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies.
    Saglio G; Guerrasio A; Tassinari A; Ponzetto C; Zaccaria A; Testoni P; Celso B; Rege Cambrin G; Serra A; Pegoraro L
    Blood; 1988 Oct; 72(4):1203-8. PubMed ID: 3167203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome abnormalities in CML.
    Hagemeijer A
    Baillieres Clin Haematol; 1987 Dec; 1(4):963-81. PubMed ID: 3332858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of M-bcr breakpoint with different chromosomal abnormalities in blast crisis Ph1-positive CML.
    Mills KI; Stewart J; Burnett AK
    Leuk Res; 1991; 15(11):999-1003. PubMed ID: 1961015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of the breakpoint sites within the M-BCR in 50 patients from Argentina with chronic myeloid leukemia.
    Giere IA; Larripa IB
    Leuk Lymphoma; 1996 Aug; 22(5-6):519-22. PubMed ID: 8882967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
    Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
    Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between the location of the breakpoint within the M-bcr and clinical parameters.
    Mills KI
    Leuk Lymphoma; 1993; 11 Suppl 1():73-9. PubMed ID: 8251922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia.
    Rozman C; Urbano-Ispizua A; Cervantes F; Rozman M; Colomer D; Féliz P; Pujades A; Vives Corrons JL
    Leukemia; 1995 Jun; 9(6):1104-7. PubMed ID: 7596178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR breakpoint subregions and blast crisis lineage in CML patients.
    Martinelli G; Chiamenti A; Gasparini P; Pignatti PF; Ambrosetti A; Zaccaria A; Buzzi M; Testoni N; Tura S; Guerrasio A
    Blood; 1992 Feb; 79(3):838-9. PubMed ID: 1732022
    [No Abstract]   [Full Text] [Related]  

  • 18. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
    Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
    Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myeloid leukemia with minor-bcr breakpoint developed hybrid type of blast crisis.
    Ohno T; Hada S; Sugiyama T; Mizumoto T; Furukawa H; Nagai K
    Am J Hematol; 1998 Apr; 57(4):320-5. PubMed ID: 9544977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene.
    Mills KI; Sproul AM; Leibowitz D; Burnett AK
    Leukemia; 1991 Nov; 5(11):937-41. PubMed ID: 1961034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.